Pilot dose–response trial of i.v. ketamine in treatment-resistant depression

References

• Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH. 2000. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351–354.
   PubMed Web of Science ®Google Scholar
• Brass EP. 2010. The gap between clinical trials and clinical practice: the use of pragmatic clinical trials to inform regulatory decision making. Clin Pharmacol Ther 87:351–355.
   PubMed Web of Science ®Google Scholar
• Bremner JD, Krystal JH, Putnam FW, Southwick SM, Marmar C, Charney DS, Mazure CM. 1998. Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress 11:125–136.
   PubMed Web of Science ®Google Scholar
• Clyde DJ. 1986. SAFTEE: data system for side effect assessment scale. Psychopharmacol Bull 22:287.
   Google Scholar
• Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, et al. 2010. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67:793–802.
   PubMed Web of Science ®Google Scholar
• Fekadu A, Wooderson S, Donaldson C, Markopoulou K, Masterson B, Poon L, Cleare AJ. 2009. A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method. J Clin Psychiatry 70:177–184.
   PubMed Web of Science ®Google Scholar
• Guy W. 1976. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: Department of Health, Eduation, and Welfare.
   Google Scholar
• Ibrahim L, Diazgranados N, Luckenbaugh DA, Machado-Vieira R, Baumann J, Mallinger AG, Zarate CA Jr. 2011. Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression. Prog Neuropsychopharmacol Biol Psychiatry 35:1155–1159.
   PubMed Web of Science ®Google Scholar
• Katalinic N, Lai R, Somogyi A, Mitchell PB, Glue P, Loo CK. 2013. Ketamine as a new treatment for depression: a review of its efficacy and adverse effects. Aust NZ J Psychiatry 47:710–727.
   PubMed Web of Science ®Google Scholar
• Larkin GL, Beautrais AL. 2011. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol 14: 1127–1131.
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Asberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382–389.
   PubMed Web of Science ®Google Scholar
• Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, et al. 2013. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomised controlled trial. Am J Psychiatry 170:1134–1142.
   PubMed Web of Science ®Google Scholar
• Posvar EL, Sedman AJ. 1989. New drugs: first time in man. J Clin Pharmacol 29:961–966.
   PubMed Web of Science ®Google Scholar
• Rose D, Fleischmann P, Wykes T, Leese M, Bindman J. 2003. Patients’ perspectives on electroconvulsive therapy: systematic review. Br Med J 326:1363.
   PubMed Web of Science ®Google Scholar
• Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. 2003. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 54: 573–583.
   PubMed Web of Science ®Google Scholar
• Shafer A. 2005. Meta-analysis of the brief psychiatric rating scale factor structure. Psychol Assess 17:324–335.
   PubMed Web of Science ®Google Scholar
• Valentine GW, Mason GF, Gomez R, Fasula M, Watzl J, Pittman B, et al. 2011. The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS. Psychiatry Res 191:122–127.
   PubMed Web of Science ®Google Scholar
• Young RC, Biggs JT, Ziegler VE, Meyer DA. 1978. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435.
   PubMed Web of Science ®Google Scholar
• Zarate CA Jr, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A, et al. 2012. Replication of ketamine’s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 71: 939–946.
   PubMed Web of Science ®Google Scholar
• Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. 2006. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856–864.
   PubMed Web of Science ®Google Scholar